Ipilimumab/NivolumabGrade 1 hypothyroidism and grade 3 secondary adrenal insufficiency

被引：0

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1985卷 / 1期

关键词：

D O I：

10.1007/s40278-023-51042-y

中图分类号：

学科分类号：

摘要：

引用

页码：272 / 272

共 50 条

[31] PembrolizumabThyroiditis, adrenal insufficiency and primary hypothyroidism: case report
[J]. Reactions Weekly, 2018, 1726 (1) : 272 - 272
[32] Ipilimumab/nivolumab/tozinameranImmune reaction and adrenal insufficiency: case report
[J]. Reactions Weekly, 2022, 1902 (1) : 257 - 257
[33] Ipilimumab/nivolumabPrimary adrenal insufficiency and acute cardiomyopathy: case report
[J]. Reactions Weekly, 2022, 1893 (1) : 192 - 192
[34] Polymorphic ventricular tachycardia in a patient with adrenal insufficiency and hypothyroidism
Izumi, C
Inoko, M
Kitaguchi, S
Himura, Y
Iga, K
Gen, H
Konishi, T
[J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1998, 62 (07): : 543 - 545
[35] PembrolizumabSecondary adrenal insufficiency and primary hypothyroidism: case report
[J]. Reactions Weekly, 2023, 1975 (1) : 308 - 308
[36] Ipilimumab/nivolumabCentral adrenal insufficiency due to hypophysitis: case report
[J]. Reactions Weekly, 2019, 1775 (1) : 268 - 268
[37] Ipilimumab/nivolumabThyroiditis, cardiac arrest and adrenal insufficiency: case report
[J]. Reactions Weekly, 2021, 1853 (1) : 258 - 258
[38] NivolumabHypophysitis, hypothyroidism and central adrenal insufficiency: case report
[J]. Reactions Weekly, 2019, 1770 (1) : 306 - 306
[39] HYPOPHYSITIS AND ADRENAL INSUFFICIENCY SECONDARY TO IPILIMUMAB AND NIVOLUMAB: A NEARLY LIFE THREATENING SIDE EFFECT OF NOVEL IMMUNOTHERAPY AGENTS
Bhalla, Samir
Hauck, Kevin
[J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S514 - S514
[40] PRIMARY HYPOTHYROIDISM ASSOCIATED WITH SECONDARY ADRENOCORTICAL INSUFFICIENCY
ROOSENS, B
MAES, E
VANSTEIRTEGHEM, A
VANHAELST, L
[J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1982, 5 (04) : 251 - 254

← 1 2 3 4 5 →